The urokinase‐type plasminogen activator system in cancer metastasis: a review

PA Andreasen, L Kjøller, L Christensen… - … journal of cancer, 1997 - Wiley Online Library
The urokinase‐type plasminogen activator (u‐PA) system consists of the serine proteinases
plasmin and u‐PA; the serpin inhibitors α2‐anti‐plasmin, PAI‐1 and PAI‐2; and the u‐PA …

The plasminogen activation system in tumor growth, invasion, and metastasis

PA Andreasen*, R Egelund, HH Petersen - Cellular and Molecular Life …, 2000 - Springer
Generation of the serine proteinase plasmin from the extracellular zymogen plasminogen
can be catalyzed by either of two other serine proteinases, the urokinase-and tissue-type …

[引用][C] DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology

VT DeVita - 2008 - books.google.com
Acclaimed by the worldwide medical community as" a staple reference text in the medical
oncologist's library"(JAMA), DeVita, Hellman, and Rosenberg's Cancer: Principles and …

Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion

AC Bellail, SB Hunter, DJ Brat, C Tan… - The international journal …, 2004 - Elsevier
The invasion of neoplastic cells into healthy brain tissue is a pathologic hallmark of gliomas
and contributes to the failure of current therapeutic modalities (surgery, radiation and …

Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population

DJ Brat, AA Castellano-Sanchez, SB Hunter, M Pecot… - Cancer research, 2004 - AACR
Necrosis and vascular proliferation are the pathologic features that distinguish the most
malignant infiltrative astrocytoma, glioblastoma (GBM), from those of lower grades. In GBM …

[HTML][HTML] Matrix metalloproteinases in human melanoma

UB Hofmann, JR Westphal, GNP van Muijen… - Journal of Investigative …, 2000 - Elsevier
Cutaneous melanoma is a highly invasive and metastatic tumor. Degradation of basement
membranes and extracellular matrix is an essential step in melanoma cell migration …

How tumors become angiogenic

N Bouck, V Stellmach, SC Hsu - Advances in cancer research, 1996 - Elsevier
Publisher Summary As normal cells progress to tumorigenicity, they must develop two
distinct new characteristics not possessed by the normal cells from which they arise: they …

[PDF][PDF] Biological and clinical aspects of plasminogen activator inhibitor type 2

EKO Kruithof, MS Baker, CL Bunn - Blood, 1995 - Citeseer
T HE PLASMINOGEN activator (PA) system is responsi-ble for the degradation of
intravascular blood clots,'while also contributing to extracellular proteolysis in a wide variety …

Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

AB Tuck, M Park, EE Sterns, A Boag… - The American journal of …, 1996 - ncbi.nlm.nih.gov
Expression of hepatocyte growth factor (HGF) and HGF receptor (HGFR, product of the met
proto-oncogene) mRNA were examined by nonisotopic in situ hybridization in a spectrum of …

uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells

RD Lester, M Jo, V Montel, S Takimoto… - The Journal of cell …, 2007 - rupress.org
Hypoxia activates genetic programs that facilitate cell survival; however, in cancer, it may
promote invasion and metastasis. In this study, we show that breast cancer cells cultured in …